AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
DIABETIC NEPHROPATHY IN HYPERTRANSFUSED PATIENTS WITH BETA-THALASSEMIA - THE ROLE OF OXIDATIVE STRESS
Authors: LOEBSTEIN R LEHOTAY DC LUO XP BARTFAY W TYLER B SHER GD
Citation: R. Loebstein et al., DIABETIC NEPHROPATHY IN HYPERTRANSFUSED PATIENTS WITH BETA-THALASSEMIA - THE ROLE OF OXIDATIVE STRESS, Diabetes care, 21(8), 1998, pp. 1306-1309
PREOPERATIVE AUTOLOGOUS BLOOD DONATIONS (PAD) IN WOMEN - ARE WE DOINGMORE HARM THAN GOOD
Authors: SHER GD CALLUM JL HALL GA FULLER K ZUBER E
Citation: Gd. Sher et al., PREOPERATIVE AUTOLOGOUS BLOOD DONATIONS (PAD) IN WOMEN - ARE WE DOINGMORE HARM THAN GOOD, Transfusion, 38(10), 1998, pp. 248-248
THERAPEUTIC LEUKAPHERESIS FOR HYPERLEUKOCYTOSIS (HIWBC) IN ADULT ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: CALLUM JL LIPTON J SHER GD MINDEN M CRUMP M CURTIS J PANTALONY D SUTTON D KEATING A MESSNER H
Citation: Jl. Callum et al., THERAPEUTIC LEUKAPHERESIS FOR HYPERLEUKOCYTOSIS (HIWBC) IN ADULT ACUTE MYELOGENOUS LEUKEMIA (AML), Transfusion, 38(10), 1998, pp. 307-307
DESFERRIOXAMINE OTOTOXICITY IN AN ADULT TRANSFUSION-DEPENDENT POPULATION
Authors: CHIODO AA ALBERTI PW SHER GD FRANCOMBE WH TYLER B
Citation: Aa. Chiodo et al., DESFERRIOXAMINE OTOTOXICITY IN AN ADULT TRANSFUSION-DEPENDENT POPULATION, Journal of otolaryngology, 26(2), 1997, pp. 116-122
PREVALENCE AND CLINICAL-SIGNIFICANCE OF HEPATITIS-G VIRUS-INFECTION IN RBC TRANSFUSION RECIPIENTS
Authors: SHER GD DIAVCITRIN O HALL GA TYLER B OLIVIERI NF CAMERON R FEINMAN SV KRAJDEN M
Citation: Gd. Sher et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF HEPATITIS-G VIRUS-INFECTION IN RBC TRANSFUSION RECIPIENTS, Transfusion, 37(9), 1997, pp. 349-349
A CLINICAL CLASSIFICATION SCHEME AND AN AUDIT OF BLOOD TO OPTIMIZE TRANSFUSION PRACTICE UTILIZATION IN PATIENTS UNDERGOING SPINAL SURGERY
Authors: CALLUM JL HALL GA KRAETSCHMER BG FULLER K ZUBER E LEIBERMAN IH SHER GD
Citation: Jl. Callum et al., A CLINICAL CLASSIFICATION SCHEME AND AN AUDIT OF BLOOD TO OPTIMIZE TRANSFUSION PRACTICE UTILIZATION IN PATIENTS UNDERGOING SPINAL SURGERY, Blood, 90(10), 1997, pp. 3286-3286
A CONTINUAL, PROSPECTIVE TRANSFUSION AUDIT OF SPECIAL PRODUCT UTILIZATION IN HEMATOLOGY ONCOLOGY PATIENTS/
Authors: CHANG H HALL GA FULLER K ZUBER E FRANCOMBE WH HAWES JH SHER GD
Citation: H. Chang et al., A CONTINUAL, PROSPECTIVE TRANSFUSION AUDIT OF SPECIAL PRODUCT UTILIZATION IN HEMATOLOGY ONCOLOGY PATIENTS/, Blood, 90(10), 1997, pp. 3288-3288
FACTORS INFLUENCING TOTAL TRANSFUSION EXPOSURE IN PREOPERATIVE AUTOLOGOUS BLOOD-DONORS UNDERGOING MAJOR SURGICAL-PROCEDURES
Authors: SHER GD HALL GA FULLER K ZUBER E
Citation: Gd. Sher et al., FACTORS INFLUENCING TOTAL TRANSFUSION EXPOSURE IN PREOPERATIVE AUTOLOGOUS BLOOD-DONORS UNDERGOING MAJOR SURGICAL-PROCEDURES, Blood, 90(10), 1997, pp. 3333-3333
THE SHORT-FORM OF THE PML-RARA GENE FUSION IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) IS ASSOCIATED MORPHOLOGICALLY WITH THE PRESENCE OF PRIMITIVE MYELOBLASTS
Authors: ALOMAR HM KHALIL S SHER GD KAMELREID S
Citation: Hm. Alomar et al., THE SHORT-FORM OF THE PML-RARA GENE FUSION IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) IS ASSOCIATED MORPHOLOGICALLY WITH THE PRESENCE OF PRIMITIVE MYELOBLASTS, Blood, 90(10), 1997, pp. 3663-3663
ALLOGENEIC RED-BLOOD-CELL TRANSFUSION IS AN INDEPENDENT RISK FACTOR IN THE DEVELOPMENT OF POSTOPERATIVE BACTERIAL-INFECTION
Authors: CHANG H HALL GA TAM F CHIAVETTA J GEERTS W GREENWOOD C MCLEOD R SHER GD
Citation: H. Chang et al., ALLOGENEIC RED-BLOOD-CELL TRANSFUSION IS AN INDEPENDENT RISK FACTOR IN THE DEVELOPMENT OF POSTOPERATIVE BACTERIAL-INFECTION, Blood, 90(10), 1997, pp. 1821-1821
RISK-FACTORS FOR AND PATHOGENESIS OF DIABETES-MELLITUS IN HYPERTRANSFUSED PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA (HBT)
Authors: LOEBSTEIN R TYLER B KWAN J OLIVIERI NF SHER GD
Citation: R. Loebstein et al., RISK-FACTORS FOR AND PATHOGENESIS OF DIABETES-MELLITUS IN HYPERTRANSFUSED PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA (HBT), Blood, 88(10), 1996, pp. 2828-2828
SERUM CYTOKINE AND CIRCULATING ADHESION MOLECULE LEVELS IN PATIENTS (PTS) WITH SICKLE-CELL DISEASE (SCD) - RELATIONSHIP TO MARKERS OF DISEASE SEVERITY AND THERAPY WITH HB F-INDUCING AGENTS
Authors: NAUMOV AO HALL GA TYLER B RIGGI K CHAN A SHER GD
Citation: Ao. Naumov et al., SERUM CYTOKINE AND CIRCULATING ADHESION MOLECULE LEVELS IN PATIENTS (PTS) WITH SICKLE-CELL DISEASE (SCD) - RELATIONSHIP TO MARKERS OF DISEASE SEVERITY AND THERAPY WITH HB F-INDUCING AGENTS, Blood, 88(10), 1996, pp. 30-30
HEPATITIS-G VIRUS-INFECTION IN RED-BLOOD-CELL TRANSFUSION-DEPENDENT PATIENTS - IDENTIFICATION OF A POPULATION OF PURE HGV POSITIVE PATIENTS
Authors: DIAYCITRIN O HALL GA TYLER B TADDIO A CAMERON R OLIVIERI NF SOOKNANNAN R KRAJDEN M FEINMAN SV SHER GD
Citation: O. Diaycitrin et al., HEPATITIS-G VIRUS-INFECTION IN RED-BLOOD-CELL TRANSFUSION-DEPENDENT PATIENTS - IDENTIFICATION OF A POPULATION OF PURE HGV POSITIVE PATIENTS, Blood, 88(10), 1996, pp. 1133-1133
EVALUATION OF A HYPERTRANSFUSION REGIMEN IN ADULT PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA (HBT) - OPTIMIZING THE SUPPRESSION OF ENDOGENOUS ERYTHROPOIESIS USING SERUM TRANSFERRIN RECEPTOR (TFR) CONCENTRATION
Authors: ALHOMAIDI A HALL GA NAUMOV AO TYLER B SHER GD
Citation: A. Alhomaidi et al., EVALUATION OF A HYPERTRANSFUSION REGIMEN IN ADULT PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA (HBT) - OPTIMIZING THE SUPPRESSION OF ENDOGENOUS ERYTHROPOIESIS USING SERUM TRANSFERRIN RECEPTOR (TFR) CONCENTRATION, Blood, 88(10), 1996, pp. 1234-1234
VALPROIC ACID (VA) IN PATIENTS (PTS) WITH AND WITHOUT SICKLE-CELL DISEASE (SCD)
Authors: SELBY R BASRAN R BLANCHETTE N NISBETBROWN E TALBOT A LISSER B CHANG L SHER GD OLIVIERI NF
Citation: R. Selby et al., VALPROIC ACID (VA) IN PATIENTS (PTS) WITH AND WITHOUT SICKLE-CELL DISEASE (SCD), Blood, 88(10), 1996, pp. 1972-1972
SEVERITY OF BETA-THALASSEMIA DUE TO GENOTYPES INVOLVING THE IVS-I-6 (T-]C) MUTATION
Authors: WAYE JS ENG B PATTERSON M WASI P CHUI DHK FRANCOMBE WH SHER GD OLIVIERI NF
Citation: Js. Waye et al., SEVERITY OF BETA-THALASSEMIA DUE TO GENOTYPES INVOLVING THE IVS-I-6 (T-]C) MUTATION, American journal of hematology, 50(1), 1995, pp. 15-19
EXTENDED THERAPY WITH INTRAVENOUS ARGININE BUTYRATE IN PATIENTS WITH BETA-HEMOGLOBINOPATHIES
Authors: SHER GD GINDER GD LITTLE J YANG SY DOVER GJ OLIVIERI NF
Citation: Gd. Sher et al., EXTENDED THERAPY WITH INTRAVENOUS ARGININE BUTYRATE IN PATIENTS WITH BETA-HEMOGLOBINOPATHIES, The New England journal of medicine, 332(24), 1995, pp. 1606-1610
ALTERATIONS IN PERIPHERAL-BLOOD LYMPHOID SUBSETS, IMMUNOGLOBULIN LEVELS AND AUTOANTIBODIES IN MULTIPLY-TRANSFUSED PATIENTS WITH BETA-THALASSEMIA
Authors: SHER GD MILONE SD TYLER B CHAN A DAVIDSON J CARSTAIRS KC
Citation: Gd. Sher et al., ALTERATIONS IN PERIPHERAL-BLOOD LYMPHOID SUBSETS, IMMUNOGLOBULIN LEVELS AND AUTOANTIBODIES IN MULTIPLY-TRANSFUSED PATIENTS WITH BETA-THALASSEMIA, Blood, 86(10), 1995, pp. 2606-2606
DNA DIAGNOSIS OF HB-S AND HB-CARIBBEAN (ALPHA(2)BETA(91-LEU-]ARG)(2))IN A JAMAICAN FAMILY
Authors: WAYE JS PATTERSON M ENG B CHUI DHK SHER GD OLIVIERI NF
Citation: Js. Waye et al., DNA DIAGNOSIS OF HB-S AND HB-CARIBBEAN (ALPHA(2)BETA(91-LEU-]ARG)(2))IN A JAMAICAN FAMILY, American journal of hematology, 47(1), 1994, pp. 33-35
DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVINGTHE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
Authors: BERKOVITCH M MEYDAN N DONSKY J COLLINS AF SHER GD MATSUI D KOREN G HACKMAN R ROIFMAN C OLIVIERI NF
Citation: M. Berkovitch et al., DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVINGTHE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY, Pediatric research, 35(4), 1994, pp. 10000158-10000158
COMBINED LIVER AND HEART-TRANSPLANTATION FOR END-STAGE IRON-INDUCED ORGAN FAILURE IN AN ADULT WITH HOMOZYGOUS BETA-THALASSEMIA
Authors: OLIVIERI NF LIU PP SHER GD DALY PA GREIG PD MCCUSKER PJ COLLINS AF FRANCOMBE WH TEMPLETON DM BUTANY J
Citation: Nf. Olivieri et al., COMBINED LIVER AND HEART-TRANSPLANTATION FOR END-STAGE IRON-INDUCED ORGAN FAILURE IN AN ADULT WITH HOMOZYGOUS BETA-THALASSEMIA, The New England journal of medicine, 330(16), 1994, pp. 1125-1127
PHARMACOKINETICS (PK) OF (IV) INTRAVENOUS ARGININE BUTYRATE (AB) IN HEMOGLOBINOPATHY PATIENTS (PTS)
Authors: MATSUI D BERKOVITCH M SHER GD HADZIALIC G OLIVIERI N ITO S DONSKY J KOREN G
Citation: D. Matsui et al., PHARMACOKINETICS (PK) OF (IV) INTRAVENOUS ARGININE BUTYRATE (AB) IN HEMOGLOBINOPATHY PATIENTS (PTS), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 175-175
RAPID HEALING OF CHRONIC LEG ULCERS DURING ARGININE BUTYRATE THERAPY IN PATIENTS WITH SICKLE-CELL DISEASE AND THALASSEMIA
Authors: SHER GD OLIVIERI NF
Citation: Gd. Sher et Nf. Olivieri, RAPID HEALING OF CHRONIC LEG ULCERS DURING ARGININE BUTYRATE THERAPY IN PATIENTS WITH SICKLE-CELL DISEASE AND THALASSEMIA, Blood, 84(7), 1994, pp. 2378-2380
DEFEROXAMINE-INDUCED VISUAL TOXICITY IN 2 UNIQUE CLINICAL SETTINGS - THE IMPORTANCE OF ONGOING ASSESSMENT OF BODY IRON BURDEN
Authors: SHER GD MURACA M SCOTT JG BUNCIC JR BRITTENHAM GM OLIVIERI NF
Citation: Gd. Sher et al., DEFEROXAMINE-INDUCED VISUAL TOXICITY IN 2 UNIQUE CLINICAL SETTINGS - THE IMPORTANCE OF ONGOING ASSESSMENT OF BODY IRON BURDEN, Blood, 84(10), 1994, pp. 10000258-10000258
LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INTHALASSEMIA - REDUCTION IN REQUIREMENT FOR TRANSFUSION AND CHELATION-THERAPY
Authors: SHER GD OLIVIERI FA MCCUSKER PJ DOVER GJ ALI M BRITTENHAM GM OLIVIERI NF
Citation: Gd. Sher et al., LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INTHALASSEMIA - REDUCTION IN REQUIREMENT FOR TRANSFUSION AND CHELATION-THERAPY, Blood, 84(10), 1994, pp. 10000258-10000258
Risultati: 1-25 | 26-36